Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Dow
Mallinckrodt
Colorcon
Merck

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Litigation Details for Boehringer Ingelheim International GMBH v. Barr Laboratories, Inc. (D. Del. 2005)

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Boehringer Ingelheim International GMBH v. Barr Laboratories, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Boehringer Ingelheim International GMBH v. Barr Laboratories, Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Boehringer Ingelheim International GMBH v. Barr Laboratories, Inc. (D. Del. 2005)

Date Filed Document No. Description Snippet Link To Document
2006-11-21 111 Exhibit A (Part 3) 3814 39:17 42123 47117,22 50:6 51122 55123 58:9,17 671§8 69117 99:6 104122105:8£06:14 108112116:1312014…the '086 patent, which 24 certainly not prepared to render in this 25 was the patent that intervened…appiication, the '94`7 18 uitimately ied to the ‘812 patent? 18 appiication, after you received this restriction…determine if there Was one, if you wish me to. 22 patent, would that be consistent with the 23 Q. So just…vague. 14 through 4 that are now in the '812 patent, if 15 A. Do you mean if 1 had submitted 15 you External link to document
2007-05-14 151 Appendix part 3 5716 10257:581? 10:5?:5919 10:5320019 10:58:0220 10:58:0621 22 23 24 t 25 231 Q. So lam just trying…who are patent 7 27796. B agents at Boehringer also? B A. Yes. 9 A. Yes, patent attorneys, patent 9 Q. And…three United States patents - U.S. Patent Nos. 4,'731,374 {“the ’3'74 patent"), 4,843,086 … the ‘{}86 patent and the `812 patent l have also been asked to compare these U.S. patents to two earlier…you would have to 11 : 0 6 : 05 20 the patent office, a patent office that one 11:02:3621 oddressa specialist External link to document
2008-02-05 191 Exhibit 1-15 12/14/99 Certified Copy of U.S. Patent 6,001,861 Relevance, Hearsay…U.S. Patent No. 4,843,086 (the “‘086 patent”) on June 27, 1989. 19. The ‘086 patent expired…10 of the ’812 patent are invalid for double patenting over claims of the ’086 patent. Case 1:05-cv…and 10 of the ’812 patent are not patentably distinct from claims of the ’086 patent. 3. …’812 patent. As an example, claim 29 of the ’086 patent differs from claim 7 of the ’812 patent only External link to document
2006-02-14 39 Motion for Reargument Particular Patents 291k328 Patents Enumerated 291k328(2) k. On`ginal Utility. Most Cited Cases 5,908,850. Cited…who hold rights in United States Patent No. 5,908,850 (“the 850 patent”), against Teva, a generic drug …Its Motion for Summary Judgment That U.S. Patent No. 5,908,850 is l_nvalid (Jul. 22, 2005) ' 2004 …Summary Judgment That United States Paterit no. 5,908,850 is Inva.lid (Sep. © 2006 Thomson/West. No Claim…of a patented drug was considered patent infringement This was so even if such use of the patented drug External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Baxter
Mallinckrodt
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.